["(S1 (S (S (NP (JJ Oxidative|0|9) (NN DNA|10|13) (NN damage|14|20)) (VP (VBZ correlates|21|31) (PP (IN with|32|36) (NP (NP (NN cell|37|41) (NN immortalization|42|57)) (CC and|58|61) (NP (NN mir-92|62|68) (NN expression|69|79)))) (PP (IN in|80|82) (NP (JJ hepatocellular|83|97) (NN carcinoma|98|107))))) (. .|107|108)))", "(S1 (S (NP (NP (NN BACKGROUND|109|119)) (: :|119|120) (S (S (NP (NN MicroRNAs|121|130) (NN expression|69|79)) (VP (VBZ has|142|145) (VP (VBN been|146|150) (ADVP (RB extensively|151|162)) (VP (VBN studied|163|170) (PP (IN in|80|82) (NP (JJ hepatocellular|83|97) (NN carcinoma|98|107))))))) (CC but|199|202) (S (NP (JJ little|203|209)) (VP (VBZ is|210|212) (VP (VBN known|213|218) (S (VP (VBG regarding|219|228) (NP (DT the|229|232) (NN relationship|233|245)))) (, ,|245|246) (SBAR (IN if|247|249) (FRAG (DT any|250|253))) (, ,|245|246) (PP (IN with|255|259) (NP (NP (NN inflammation|260|272)) (, ,|245|246) (NP (NP (NN production|274|284)) (PP (IN of|285|287) (NP (NP (JJ reactive|288|296) (NN oxygen|297|303) (NNS species|304|311)) (PRN (-LRB- -LRB-|312|313) (NP (NN ROS|313|316)) (-RRB- -RRB-|316|317))))) (, ,|245|246) (NP (NN host|319|323) (POS 's|323|325) (NN repair|326|332) (NNS mechanisms|333|343)) (CC and|58|61) (NP (NN cell|89|93) (NN immortalization|353|368)))))))) (. .|107|108))))", "(S1 (S (NP (DT This|370|374) (NN study|375|380)) (VP (VBD aimed|381|386) (PP (PP (IN at|86|88) (S (VP (VBG assessing|390|399) (NP (NP (DT the|229|232) (NN extent|404|410)) (PP (IN of|285|287) (NP (NP (JJ oxidative|414|423) (NN DNA|424|427) (NN damage|428|434)) (PRN (-LRB- -LRB-|312|313) (NP (NN 8-hydroxydeoxyguanosine|436|459)) (: -|437|438) (NP (NN 8-OHdG|462|468)) (-RRB- -RRB-|316|317)))) (PP (IN in|80|82) (NP (NP (JJ different|473|482) (NNS phases|483|489)) (PP (IN of|285|287) (NP (DT the|229|232) (JJ carcinogenetic|497|511) (NN process|512|519)))))) (, ,|245|246) (PP (IN in|80|82) (NP (NP (NN relation|233|241)) (PP (TO to|87|89) (NP (NN DNA|424|427) (NN repair|326|332) (NN gene|504|508) (NN polymorphism|552|564))))) (, ,|245|246) (NP (JJ telomeric|566|575) (NN dysfunction|576|587))))) (CC and|344|347) (PP (TO to|178|180) (NP (NP (DT the|229|232) (NN expression|131|141)) (PP (IN of|285|287) (NP (NP (JJ several|613|620) (NNS microRNAs|621|630)) (, ,|245|246) (NP (NP (JJ non-coding|632|642) (NNS genes|643|648)) (VP (VBN involved|649|657) (PP (IN in|102|104) (NP (NP (JJ post-transcriptional|661|681) (NN regulation|682|692)) (, ,|245|246) (NP (NN cell|180|184) (NN proliferation|699|712)) (, ,|245|246) (NP (NN differentiation|714|729)) (CC and|344|347) (NP (NN death|734|739)))))))))))) (. .|368|369)))", "(S1 (S (NP (NP (NNS METHODS|741|748)) (: :|119|120) (S (NP (NP (NN Tissue|750|756) (NNS samples|757|764)) (VP (VBN obtained|765|773) (PP (CC either|774|780) (PP (IN at|177|179) (NP (NN surgery|784|791))) (, ,|245|246) (NP (NP (NP (JJ -LSB-neoplastic|793|804)) (PRN (-LRB- -LRB-|312|313) (NP (NN HCC|806|809)) (-RRB- -RRB-|316|317))) (CC and|344|347) (NP (NP (JJ adjacent|815|823) (JJ non-cancerous|824|837) (JJ cirrhotic|838|847) (NNS tissues|848|855)) (PRN (-LRB- -LRB-|312|313) (NP (NN NCCT|857|861)) (-RRB- -RRB-|316|317))) (-RRB- -RSB-|862|863))) (PP (IN at|177|179) (NP (NP (NN percutaneous|867|879)) (CC or|356|358) (NP (JJ laparoscopic|883|895) (NN biopsy|896|902)))) (PRN (-LRB- -LRB-|312|313) (NP (NP (NP (NNS patients|904|912)) (PP (IN with|255|259) (NP (NP (NN HCV|918|921)) (CC or|356|358) (NP (JJ HBV-related|925|936) (NN hepatitis|937|946))))) (CC or|356|358) (NP (NP (NNS patients|904|912)) (VP (VBG undergoing|959|969) (NP (NN cholecystectomy|970|985))))) (-RRB- -RRB-|316|317)))) (VP (VBD were|987|991) (VP (VBN analysed|992|1000) (PP (IN for|1001|1004) (NP (NP (NP (NN 8-OHdG|462|468)) (PRN (-LRB- -LRB-|312|313) (NP (JJ HPLC-ED|1013|1020)) (-RRB- -RRB-|316|317))) (, ,|245|246) (NP (NP (NP (NN OGG1|1023|1027)) (PRN (-LRB- -LRB-|312|313) (NP (DT a|177|178) (NN DNA|424|427) (NN repair|326|332) (NN gene|504|508)) (-RRB- -RRB-|316|317)) (NP (NP (NN polymorphism|552|564)) (PRN (-LRB- -LRB-|312|313) (NP (NN PCR-RFLP|1062|1070)) (-RRB- -RRB-|316|317))) (, ,|245|246) (NP (NN telomerase|1073|1083) (NN activity|1084|1092)) (, ,|245|246) (NP (NN telomere|1094|1102) (NN length|1103|1109))) (PRN (-LRB- -LRB-|312|313) (NP (NN T/S|1111|1114)))) (, ,|245|246))) (PP (IN by|1116|1118) (NP (NP (NN RT-PCR|1119|1125) (-RRB- -RRB-|316|317)) (, ,|245|246) (NP (NN Taqman|1128|1134) (NN microRNA|621|629) (NN assay|1144|1149)) (CC and|344|347) (NP (NP (NN Bad/Bax|1154|1161) (NN mRNA|1162|1166)) (PRN (-LRB- -LRB-|312|313) (NP (NN RT-PCR|1119|1125)) (-RRB- -RRB-|316|317)))))))) (. .|368|369))))", "(S1 (S (S (NP (NP (NP (JJ Fifty-eight|1177|1188) (NNS samples|757|764)) (PP (IN from|1197|1201) (NP (CD 29|1202|1204) (NN HCC|806|809) (NNS patients|904|912))) (-LRB- -LRB-|312|313) (VP (VBN obtained|765|773) (PP (IN in|225|227) (NP (DT both|1231|1235) (JJ neoplastic|794|804) (CC and|344|347) (JJ peritumoral|1251|1262) (NNS tissues|848|855)))) (-RRB- -RRB-|316|317)) (, ,|245|246) (NP (NP (NP (CD 22|1273|1275)) (PP (IN from|1197|1201) (NP (JJ chronic|1281|1288) (NN hepatitis|937|946)))) (PRN (-LRB- -LRB-|312|313) (NP (NN CH|1300|1302)) (-RRB- -RRB-|316|317))) (CC and|344|347) (NP (NP (CD 10|1308|1310) (NNS controls|1311|1319)) (PRN (-LRB- -LRB-|312|313) (NP (NN cholecystectomy|970|985) (NNS patients|904|912)) (: -|437|438) (NP (NN CON|1348|1351)) (-RRB- -RRB-|316|317)))) (VP (VBD were|987|991) (VP (VBN examined|1358|1366)))) (. .|368|369)))", "(S1 (S (NP (NP (NNS RESULTS|1368|1375)) (: :|748|749) (S (NP (NN Eight-OHdG|1377|1387) (NNS levels|1388|1394)) (VP (VBD were|987|991) (ADVP (RB significantly|1400|1413)) (ADJP (ADJP (JJR higher|1414|1420)) (PP (IN in|260|262) (NP (NP (NN HCC|806|809)) (CC and|344|347) (NP (NN NCCT|857|861)))) (PP (IN than|1437|1441) (PP (IN in|260|262) (NP (NP (NN CH|1300|1302)) (CC and|344|347) (NP (NP (NN CON|1348|1351)) (PRN (-LRB- -LRB-|312|313) (NP (NN p=0.001|1457|1464)) (-RRB- -RRB-|316|317))))))))) (. .|368|369))))", "(S1 (S (S (NP (NN Telomerase|1467|1477) (NN activity|1084|1092)) (VP (VBD was|1487|1490) (ADJP (ADJP (RB significantly|1400|1413) (JJR higher|1414|1420)) (PP (IN in|260|262) (NP (NN HCC|806|809))) (PP (IN than|1437|1441) (PP (IN in|260|262) (NP (DT the|400|403) (VBG remaining|1531|1540) (NNS subgroups|1541|1550)))) (PRN (-LRB- -LRB-|312|313) (NP (NN p=0.002|1552|1559)) (-RRB- -RRB-|316|317))))) (: ;|1560|1561) (S (ADVP (RB conversely|1562|1572)) (NP (NN T/S|1111|1114)) (VP (VBD was|1487|1490) (ADJP (RB significantly|1400|1413) (JJR lower|1595|1600)) (PP (IN in|396|398) (NP (NP (NN HCC|806|809)) (PRN (-LRB- -LRB-|312|313) (NP (NN p=0.05|1609|1615)) (-RRB- -RRB-|316|317)))))) (. .|368|369)))", "(S1 (S (S (NP (NP (CD MiR-199a-b|1618|1628)) (, ,|317|318) (NP (CD -195|1630|1634)) (, ,|317|318) (NP (CD -122|1636|1640)) (, ,|317|318) (NP (CD -92a|1642|1646)) (CC and|344|347) (NP (CD -145|1651|1655))) (VP (VBD were|987|991) (VP (VBN down-regulated|1661|1675) (PP (IN in|396|398) (NP (NP (DT the|400|403) (NN majority|1683|1691)) (PP (IN of|411|413) (NP (NNS HCCs|1695|1699))))) (SBAR (IN while|1700|1705) (S (NP (NN miR-222|1706|1713)) (VP (VBD was|1487|1490) (VP (VBN up-regulated|1718|1730)))))))) (. .|368|369)))", "(S1 (S (S (NP (DT A|426|427) (JJ positive|1734|1742) (NN correlation|1743|1754)) (VP (VBD was|1487|1490) (VP (VBN observed|1759|1767) (PP (IN among|1768|1773) (NP (NP (NN 8-OHdG|462|468) (NNS levels|1388|1394)) (, ,|317|318) (NP (NN disease|1789|1796) (NN stage|1797|1802)) (, ,|317|318) (NP (NN telomerase|1073|1083) (NN activity|1084|1092)) (, ,|317|318) (NP (NN OGG1|1023|1027) (NNS polymorphisms|1830|1843)) (CC and|344|347) (NP (NN ALT/GGT|1848|1855) (NNS levels|1388|1394))))))) (. .|368|369)))", "(S1 (S (S (PP (IN In|1864|1866) (NP (NN HCC|806|809))) (, ,|519|520) (NP (NN miR-92|1872|1878) (NN expression|599|609)) (VP (VBD correlated|1890|1900) (ADVP (RB positively|1901|1911)) (PP (IN with|913|917) (NP (NP (NN telomerase|1073|1083) (NN activity|1084|1092)) (, ,|519|520) (NP (NN 8-OHdG|462|468) (NNS levels|1388|1394)) (CC and|344|347) (NP (NN Bad/Bax|1154|1161) (NN mRNA|1162|1166)))))) (. .|368|369)))", "(S1 (S (NP (NP (NNS CONCLUSIONS|1970|1981)) (: :|748|749) (S (NP (DT The|1983|1986) (JJ above|1987|1992) (NNS findings|1993|2001)) (VP (VP (VBP confirm|2002|2009) (NP (NP (DT the|400|403) (NN accumulation|2014|2026)) (, ,|519|520) (PP (IN in|396|398) (NP (NP (DT the|400|403) (NN progression|2035|2046)) (PP (IN of|411|413) (NP (JJ chronic|1281|1288) (NN liver|2058|2063) (NN damage|428|434))) (PP (TO to|533|535) (NP (NN HCC|806|809))))) (, ,|519|520) (PP (IN of|411|413) (NP (DT a|359|360) (JJ ROS-mediated|2084|2096) (JJ oxidative|414|423) (NN DNA|424|427) (NN damage|428|434))))) (, ,|519|520) (CC and|588|591) (VP (VBP suggest|2123|2130) (SBAR (IN that|2131|2135) (S (NP (DT this|2136|2140)) (VP (VP (VBZ correlates|2141|2151) (PP (IN with|913|917) (NP (NP (NN induction|2157|2166)) (PP (IN of|411|413) (NP (NN telomerase|1073|1083) (NN activity|1084|1092)))))) (CC and|588|591) (, ,|519|520) (PP (IN as|390|392) (NP (DT a|381|382) (JJ novel|2200|2205) (NN finding|1993|2000))) (, ,|519|520) (PP (IN with|913|917) (NP (NP (NN over-expression|2220|2235)) (PP (IN of|411|413) (NP (NP (NN miR-92|1872|1878)) (, ,|519|520) (NP (NP (DT a|387|388) (NN microRNA|621|629)) (SBAR (WHNP (WDT that|2131|2135)) (S (VP (VBZ plays|2263|2268) (NP (DT a|387|388) (NN role|2271|2275)) (PP (PP (IN in|396|398) (NP (PDT both|1231|1235) (DT the|400|403) (JJ apoptotic|2288|2297) (NN process|512|519))) (CC and|588|591) (PP (IN in|396|398) (NP (JJ cellular|2313|2321) (NN proliferation|699|712) (NNS pathways|2336|2344)))))))))))))))))) (. .|739|740))))"]